Literature DB >> 18064479

Outcome of surgical management of persistent or recurrent neck mass in patients with nasopharyngeal carcinoma after radiotherapy.

Cheng-Yu Lin1, Sen-Tien Tsai, Ying-Tai Jin, Ming-Wei Yang, I-Chun Yeh, Jenn-Ren Hsiao.   

Abstract

Nasopharyngeal carcinoma (NPC) patients may have persistent or recurrent neck masses following radiotherapy. The clinicopathological features for these two subgroups are not fully characterized, however. In this study, we reviewed our experiences in patients with neck masses underwent either local excision or neck dissection. Between 1990 and 2004, 37 NPC patients who had persistent (n=18) or recurrent (n=19) neck masses following radiotherapy were enrolled. The clinical and pathological parameters were measured. Squamous cell carcinoma was found in the resected specimens of 72.2% of the patients (13/18) with persistent neck mass and 89.5% of the analogs with the recurrent form (17/19). Extra-nodal tumor extension was noted in 53.8% (7/13) of persistent neck malignancies and 64.7% (11/17) of the recurrent variants. At the time of the neck surgery, individuals with persistent neck malignancies had fewer concomitant distant failures (23.1%, 3/13) as compared to their counterparts with the recurrent form (58.8%, 10/17) (P=0.07). At the end of the follow-up, however, the rates of local and/or distant failures were both high for the persistent (92.3%, 12/13) and recurrent groups (76.5%, 13/17). In conclusion, following radiotherapy for NPC, both persistent and recurrent neck masses were associated with a high rate of squamous cell carcinoma. Although patients with persistent neck malignancies have significantly fewer additional sites of failures at the time of their neck surgeries, they tend to develop local and/or distant recurrences later during follow-up.

Entities:  

Mesh:

Year:  2007        PMID: 18064479     DOI: 10.1007/s00405-007-0552-1

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  23 in total

1.  Submental metastases from nasopharyngeal carcinoma.

Authors:  A T Ahuja; S F Leung; P Teo; M Ying; W King; C Metreweli
Journal:  Clin Radiol       Date:  1999-01       Impact factor: 2.350

Review 2.  Pathogenesis and treatment of nasopharyngeal carcinoma.

Authors:  Anthony T C Chan; Peter M L Teo; Dolly P Huang
Journal:  Semin Oncol       Date:  2004-12       Impact factor: 4.929

3.  Survival outcome of patients with nasopharyngeal carcinoma with first local failure: a study by the Hong Kong Nasopharyngeal Carcinoma Study Group.

Authors:  Kwok Hung Yu; Sing Fai Leung; Stewart Yuk Tung; Benny Zee; Daniel T T Chua; Wai Man Sze; Stephen C K Law; Michael K M Kam; To Wai Leung; Jonathan S T Sham; Anne W M Lee; Joseph S K Au; Edwin P Hui; Wing Kin Sze; Ashley C K Cheng; T K Yau; Roger K C Ngan; Frank C S Wong; Gordon K H Au; Anthony T C Chan
Journal:  Head Neck       Date:  2005-05       Impact factor: 3.147

4.  Nasopharyngectomy in the treatment of recurrent nasopharyngeal carcinoma: a twelve-year experience.

Authors:  W W King; P K Ku; C O Mok; P M Teo
Journal:  Head Neck       Date:  2000-05       Impact factor: 3.147

5.  Long-term observation after radiotherapy for nasopharyngeal carcinoma (NPC).

Authors:  W Z Chen; D L Zhou; K S Luo
Journal:  Int J Radiat Oncol Biol Phys       Date:  1989-02       Impact factor: 7.038

6.  Management of extensive cervical nodal metastasis in nasopharyngeal carcinoma after radiotherapy: a clinicopathological study.

Authors:  W I Wei; W K Ho; A C Cheng; X Wu; G K Li; J Nicholls; P W Yuen; J S Sham
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2001-12

7.  Clinical features and management of distant metastases of nasopharyngeal carcinoma.

Authors:  S F Leung; P M Teo; W W Shiu; S Y Tsao; T W Leung
Journal:  J Otolaryngol       Date:  1991-02

8.  Longterm results after resection of simultaneous and sequential lung and liver metastases from colorectal carcinoma.

Authors:  Tommaso Claudio Mineo; Vincenzo Ambrogi; Giuseppe Tonini; Patrizio Bollero; Mario Roselli; Davide Mineo; Italo Nofroni
Journal:  J Am Coll Surg       Date:  2003-09       Impact factor: 6.113

9.  Presence of the latent membrane protein 1 gene in nasopharyngeal swabs from patients with mucosal recurrent nasopharyngeal carcinoma.

Authors:  Ngan-Ming Tsang; Chi-Cheng Chuang; Chen-Kan Tseng; Sheng-Po Hao; Tseng-Tong Kuo; Chien-Yu Lin; Ping-Ching Pai
Journal:  Cancer       Date:  2003-12-01       Impact factor: 6.860

10.  Distant metastases of nasopharyngeal carcinoma: a study of 256 male patients.

Authors:  A Ahmad; S Stefani
Journal:  J Surg Oncol       Date:  1986-11       Impact factor: 3.454

View more
  5 in total

1.  [Treatment results of nasopharyngeal carcinoma in adults].

Authors:  M Jakob; M Manz; S Herberhold; A Schröck; A O H Gerstner; H Schüller; K W G Eichhorn
Journal:  HNO       Date:  2012-12       Impact factor: 1.284

2.  The pattern of relapse and survival of elective irradiation of the upper neck for stage N0 nasopharyngeal carcinoma.

Authors:  Xiayun He; Ziqiang Pan; Xiaomao Guo; Ming Ye; Zhen Zhang; Shaoqin He; Taifu Liu
Journal:  Radiat Oncol       Date:  2012-03-19       Impact factor: 3.481

3.  Salvage surgery for neck residue or recurrence of nasopharyngeal carcinoma after primary radiotherapy: options of surgical methods and regions.

Authors:  Sheng-ye Wang; Jian-lin Lou; Jianxiang Chen; Su-zhan Zhang; Liang Guo
Journal:  World J Surg Oncol       Date:  2016-03-25       Impact factor: 2.754

4.  Nasopharyngeal carcinoma: United Kingdom National Multidisciplinary Guidelines.

Authors:  R Simo; M Robinson; M Lei; A Sibtain; S Hickey
Journal:  J Laryngol Otol       Date:  2016-05       Impact factor: 1.469

5.  The diagnostic and prognostic values of plasma Epstein-Barr virus DNA for residual cervical lymphadenopathy in nasopharyngeal carcinoma patients: a retrospective study.

Authors:  Sai-Lan Liu; Xue-Song Sun; Xiao-Yun Li; Lin-Quan Tang; Qiu-Yan Chen; Huan-Xin Lin; Yu-Jing Liang; Jin-Jie Yan; Chao Lin; Shan-Shan Guo; Li-Ting Liu; Yang Li; Hao-Jun Xie; Qing-Nan Tang; Hu Liang; Ling Guo; Hai-Qiang Mai
Journal:  Cancer Commun (Lond)       Date:  2019-03-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.